AstraZeneca’s vaccine contains more than 1,000 proteins derived from human cells, and EDTA helps them stay in the bloodstream. The proteins bind to a blood component called platelet factor 4 and then form structures that catalyze antibody production.
Dr. Greinacher explained his hypothesis to The Wall Street Journal May 13: When the body’s immune response is kickstarted, the vaccine can trigger an ancient defense mechanism that spirals out of control and causes bleeding and clotting.
He is working to confirm his theory and hopes drugmakers will cooperate with his efforts so he can obtain greater access to their production processes.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
